# Efficacy of Three Dimensional Transesophageal Echocardiography for Percutaneous Device Closure in Atrial Septal Defect

Study · id `cardio:ct-nct02097758` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT02097758](<https://clinicaltrials.gov/study/NCT02097758>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT02097758

Browse, organ or system: Heart  
Browse, condition area: Valve and congenital heart disease  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 100 participants.

## Technical summary

Registry record NCT02097758. Allocation not applicable; no masking; primary purpose diagnostic. Start 2014-03 (registry gives no type); primary completion 2026-12 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; allocation not applicable; no masking; primary purpose diagnostic
- Phase: Not applicable
- Enrolled: 100 participants (planned count; ClinicalTrials.gov record NCT02097758, source copy `cardio:ctgov-nct02097758-2025-02-07`, retrieved 2026-10-26)
- Start date: 2014-03 (registry gives no type) (ClinicalTrials.gov record NCT02097758, source copy `cardio:ctgov-nct02097758-2025-02-07`, retrieved 2026-10-26)
- Primary completion: 2026-12 (anticipated) (ClinicalTrials.gov record NCT02097758, source copy `cardio:ctgov-nct02097758-2025-02-07`, retrieved 2026-10-26)
- Completion: 2026-12 (anticipated) (ClinicalTrials.gov record NCT02097758, source copy `cardio:ctgov-nct02097758-2025-02-07`, retrieved 2026-10-26)
- Countries: South Korea (ClinicalTrials.gov record NCT02097758, source copy `cardio:ctgov-nct02097758-2025-02-07`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "RECRUITING" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct02097758-2025-02-07`, retrieved 2026-10-26)

## The registry's words

- Brief title: Efficacy of Three Dimensional Transesophageal Echocardiography for Percutaneous Device Closure in Atrial Septal Defect
- Acronym: ASD
- Condition: Atrial Septal Defect
- Condition: Successful Device Closure
- Intervention (Device): Transcatheter device closure
- Lead sponsor: Asan Medical Center
- Lead sponsor class: OTHER

## Connected pages

- Registry condition terms include this condition: Adult congenital heart disease (`cardio:adult-congenital-heart-disease`)
- Registry condition terms include this condition: Congenital heart disease (`core:congenital-heart-disease`)
- Registry lists this organization as the lead sponsor: Asan Medical Center (`cardio:org-asan-medical-center`)

## Provenance

Content hash: 8e48411a8eb733fd6915ed106610fab04eea5ca9500736a6e4923be315e57e14
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
